BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,325,621 | -68.5% | 270,536 | -64.8% | 0.04% | -72.9% |
| Q4 2022 | $39,148,936 | +340.3% | 768,078 | +365.3% | 0.14% | +241.5% |
| Q3 2022 | $8,892,000 | -57.7% | 165,089 | -49.6% | 0.04% | -53.9% |
| Q2 2022 | $21,028,000 | -21.1% | 327,373 | -4.8% | 0.09% | -4.3% |
| Q1 2022 | $26,668,000 | +118.5% | 343,933 | +141.9% | 0.09% | +138.5% |
| Q4 2021 | $12,204,000 | -26.7% | 142,165 | -31.3% | 0.04% | -32.8% |
| Q3 2021 | $16,653,000 | -11.5% | 207,042 | -11.4% | 0.06% | -12.1% |
| Q2 2021 | $18,817,000 | +532.5% | 233,753 | +562.6% | 0.07% | +407.7% |
| Q1 2021 | $2,975,000 | -41.7% | 35,277 | -44.6% | 0.01% | -40.9% |
| Q4 2020 | $5,107,000 | -14.3% | 63,640 | -14.1% | 0.02% | -4.3% |
| Q3 2020 | $5,961,000 | -58.7% | 74,122 | -55.8% | 0.02% | -68.5% |
| Q2 2020 | $14,446,000 | +431.3% | 167,778 | +401.1% | 0.07% | +305.6% |
| Q1 2020 | $2,719,000 | -91.5% | 33,480 | -91.2% | 0.02% | -82.9% |
| Q4 2019 | $31,918,000 | +10.3% | 381,704 | +15.4% | 0.10% | -1.9% |
| Q3 2019 | $28,927,000 | -42.4% | 330,716 | -46.0% | 0.11% | -40.9% |
| Q2 2019 | $50,190,000 | +4.2% | 612,829 | +3.5% | 0.18% | -1.1% |
| Q1 2019 | $48,163,000 | +24.7% | 592,343 | +0.9% | 0.18% | +6.4% |
| Q4 2018 | $38,637,000 | -36.9% | 587,014 | -26.1% | 0.17% | -23.2% |
| Q3 2018 | $61,227,000 | +84.6% | 794,238 | +76.8% | 0.22% | +64.7% |
| Q2 2018 | $33,175,000 | +117.8% | 449,277 | +91.8% | 0.14% | +94.3% |
| Q1 2018 | $15,232,000 | – | 234,196 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |